estradiol valerate and estradiol valerate/dienogest

FDA Drug Profile — Natazia, Estradiol Valerate and Estradiol Valerate/Dienogest

estradiol valerate and estradiol valerate/dienogest is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Natazia, Estradiol Valerate and Estradiol Valerate/Dienogest. Available dosage form: kit.

Drug Details

Generic Name
estradiol valerate and estradiol valerate/dienogest
Brand Names
Natazia, Estradiol Valerate and Estradiol Valerate/Dienogest
Application Number
NDA022252
Sponsor
Bayer HealthCare Pharmaceuticals Inc.
NDC Codes
2
Dosage Forms
KIT
Routes
N/A
Active Ingredients
N/A

Indications and Usage

1 INDICATIONS AND USAGE • Estradiol Valerate and Estradiol Valerate/Dienogest is an estrogen/progestin COC indicated for use by women to prevent pregnancy. ( 1 ) • Treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception. ( 1.2 ) • The efficacy of Estradiol Valerate and Estradiol Valerate/Dienogest in women with a body mass index (BMI) of >30 kg/m 2 has not been evaluated. ( 1 , 8.8 ) 1.1 Oral Contraception Estradiol Valerate and Estradiol Valerate/Dienogest is indicated for use by women to prevent pregnancy. The efficacy of Estradiol Valerate and Estradiol Valerate/Dienogest in women with a body mass index (BMI) of > 30 kg/m 2 has not been evaluated. 1.2 Heavy Menstrual Bleeding Estradiol Valerate and Estradiol Valerate/Dienogest is also indicated for the treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception [see Clinical Studies ( 14.2 )].